DE69826287D1 - Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung - Google Patents
Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutungInfo
- Publication number
- DE69826287D1 DE69826287D1 DE69826287T DE69826287T DE69826287D1 DE 69826287 D1 DE69826287 D1 DE 69826287D1 DE 69826287 T DE69826287 T DE 69826287T DE 69826287 T DE69826287 T DE 69826287T DE 69826287 D1 DE69826287 D1 DE 69826287D1
- Authority
- DE
- Germany
- Prior art keywords
- phospholamic
- banner
- coronary circulation
- increase coronary
- phospholamban
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88226297A | 1997-06-25 | 1997-06-25 | |
| US882262 | 1997-06-25 | ||
| US93711897A | 1997-09-24 | 1997-09-24 | |
| US937118 | 1997-09-24 | ||
| PCT/FI1998/000559 WO1999000132A1 (en) | 1997-06-25 | 1998-06-25 | Use of phospholamban inhibitors for increasing coronary flow |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69826287D1 true DE69826287D1 (de) | 2004-10-21 |
| DE69826287T2 DE69826287T2 (de) | 2005-10-27 |
Family
ID=27128657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69826287T Expired - Fee Related DE69826287T2 (de) | 1997-06-25 | 1998-06-25 | Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1001774B1 (de) |
| JP (1) | JP2002506457A (de) |
| AT (1) | ATE275955T1 (de) |
| AU (1) | AU7921698A (de) |
| BR (1) | BR9810335A (de) |
| CA (1) | CA2294550A1 (de) |
| DE (1) | DE69826287T2 (de) |
| ES (1) | ES2227846T3 (de) |
| WO (1) | WO1999000132A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968959A (en) * | 1997-12-12 | 1999-10-19 | Orion Corporation | Method for the prevention and treatment of stunned myocardium |
| GB0611781D0 (en) * | 2006-06-14 | 2006-07-26 | Argenta Discovery Ltd | 2-Oxo-2H-Chromene Compounds |
-
1998
- 1998-06-25 DE DE69826287T patent/DE69826287T2/de not_active Expired - Fee Related
- 1998-06-25 BR BR9810335-0A patent/BR9810335A/pt not_active IP Right Cessation
- 1998-06-25 JP JP50530799A patent/JP2002506457A/ja not_active Ceased
- 1998-06-25 WO PCT/FI1998/000559 patent/WO1999000132A1/en active IP Right Grant
- 1998-06-25 CA CA002294550A patent/CA2294550A1/en not_active Abandoned
- 1998-06-25 AT AT98929466T patent/ATE275955T1/de not_active IP Right Cessation
- 1998-06-25 EP EP98929466A patent/EP1001774B1/de not_active Expired - Lifetime
- 1998-06-25 ES ES98929466T patent/ES2227846T3/es not_active Expired - Lifetime
- 1998-06-25 AU AU79216/98A patent/AU7921698A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU7921698A (en) | 1999-01-19 |
| EP1001774A1 (de) | 2000-05-24 |
| DE69826287T2 (de) | 2005-10-27 |
| WO1999000132A1 (en) | 1999-01-07 |
| ES2227846T3 (es) | 2005-04-01 |
| BR9810335A (pt) | 2000-09-05 |
| ATE275955T1 (de) | 2004-10-15 |
| CA2294550A1 (en) | 1999-01-07 |
| EP1001774B1 (de) | 2004-09-15 |
| JP2002506457A (ja) | 2002-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69837295D1 (de) | Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1 | |
| DE69516866D1 (de) | Stereochemische wortmanninderivate | |
| ES2128283T1 (es) | Profarmacos de inhibidores de trombina. | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| NO942641L (no) | Inhibisjon av fosfatidylinositol 3-kinase med wortmannin og analoger derav | |
| PE44895A1 (es) | Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero | |
| DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
| ATE218336T1 (de) | Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom | |
| DK130387D0 (da) | Transglutaminase inhibitorer | |
| ATE241354T1 (de) | Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis | |
| ES2188906T3 (es) | Inhibidores de la enzima de conversion de la interleucina-1beta a base de sulfonamida. | |
| DE69205859D1 (de) | Verwendung von oberflächenaktiven Mitteln zur Verbesserung des Rückflusses von Venenkathetern. | |
| DE69102936T2 (de) | Bis(alkyl-substituierte-4-hydroxyphenylthio)alkan-Analoga als Inhibitoren der Kataraktentstehung. | |
| DE69735230D1 (de) | Sulfonamid-substituierte asparaginsäuren als inhibitoren von interleukin-1beta-konvertierenden enzymen | |
| FR2599752B1 (fr) | Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine | |
| ATE212845T1 (de) | Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen | |
| DE69826287D1 (de) | Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung | |
| ATE181240T1 (de) | Verwendung von somatostatinanalogen zur behandlung von melanomen | |
| NO995132D0 (no) | Fremgangsmåte for reduksjon av fibrinogen | |
| ES2089281T3 (es) | Nuevos derivados de 2-mercaptometileno-tetrahidronaftaleno y 2-carboxamida indanos como inhibidores de la encefalinasa. | |
| ATE231721T1 (de) | Verwendung von tropolon derivate zur hemmung des inositmono phosphatase | |
| NO994339D0 (no) | Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat | |
| ES2148057A1 (es) | Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 | |
| KR940018805U (ko) | 신발안창의 쿠션을 조절하는 쿠션판 | |
| KR950000181U (ko) | 불소화합물이 침탄처리된 가죽을 바닥으로 사용한 보울링화 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |